Remove Big Data Remove Bioinformatics Remove Engineer Remove Medicine
article thumbnail

Big data – charting a new path to drug discovery and development

Drug Discovery World

For example, Sanofi, Pfizer, Gilead, Novartis, BMS, Genentech, and Bayer have all announced significant alliances to integrate these big data technologies into drug discovery operations. This knowledge enabled cell line engineering campaigns that boosted yield and stability across various production bottlenecks.

article thumbnail

The future of AI drug discovery & development in immunology and GPCR research

pharmaphorum

Verily’s Immune Profiler platform is “a discovery engine consisting of proprietary immune profiling lab workflow, growing multi-omic database, and advanced analytical tools”. Kim recognised then, he said, that better tools for medicine needed to be developed, and that they still do.

article thumbnail

How big data analytics can make personalised care a reality

Drug Discovery World

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care. He holds an MS degree in Statistics and a BS-equivalent in Bioengineering.